Business
Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference
Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025 at 8:40 a.m. ET.
About this update from Haemonetics Corporation
BOSTON , May 30, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon , President and CEO, will participate in a fireside chat with investors at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025 at 8:40 a.m. ET . The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations website or at the following link: https://event.webcasts.com/starthere.jsp?ei=1721260&tp_key=3096fdc651&tp_special=8 A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics' Investor Relations website. ABOUT HAEMONETICS Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com . Investor Contacts: Olga Guyette , Vice President-Investor Relations & Treasury (781) 356-9763 [email protected] David Trenk , Manager-Investor Relations (203) 733-4987 [email protected] Media Contact: Josh Gitelson , Sr. Director-Global Communications (781) 356-9776 [email protected] View original content to download multimedia: https://www.prnewswire.com/news-releases/haemonetics-to-present-at-goldman-sachs-46th-annual-global-healthcare-conference-302468741.html SOURCE Haemonetics Corporation
View stock analysis, news, and events for Haemonetics Corporation